Peroxisome proliferator-activated receptor-γ agonist inhibited aldosterone-induced mesangial cell proliferation
Aihua Zhang
Abstract
Aihua Zhang
Abstract
Objective:To investigate the role of oxidative stress in aldosterone(ALDO)-induced mesangial cell(MC)proliferation, and to detect the inhibitory effect of peroxisome prnliferator-activated receptor-y(PPARγ)agonist on ALDO-induced MC proliferation. Methods:Mouse primary mesangial cells were treated with ALDO(100 nmol/L)in the presence or absence of N-acytosistin(NAC, 10μmol/L)or Rosiglitazone(1.0,2.3,5.0,10.0μmol/L).MC proliferation was measured by ~3H-thymidine incoporation.MC cell-cycle was analyzed by flow cytometry.Cyclin D1 and cyclin A expression was determined by Western blot analysis.Reactive oxygen species (ROS)production was measured by 2',7'-dichlorofluorescein diacetate(DCFDA)fluorescence.Results:①ALDO-induced MC prolif- eration was inhibited by PPARγagonist rosiglitazone in dose-dependent manner in mouse mesangial cells;②ALDO increased cell number in S-and G_2/M phase,which was inhibited by rosiglitazone;③Rosiglitazone reduced ALDO-induced eyelin D1 and cyclin A expression in dose-dependent manner;④NAC significantly inhibited ALDO-induced MC proliferation.Rosiglitazone dose-dependently inhibited ALDO-induced ROS production.Conclusions:ROS involved in ALDO-induced MC proliferation.PPARγligand rosiglitazone blocked ALDO-induced MC proliferation via inhibition of ROS production.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the role of oxidative stress in aldosterone(ALDO)-induced mesangial cell(MC)proliferation, and to detect the inhibitory effect of peroxisome prnliferator-activated receptor-y(PPARγ)agonist on ALDO-induced MC proliferation. Methods:Mouse primary mesangial cells were treated with ALDO(100 nmol/L)in the presence or absence of N-acytosistin(NAC, 10μmol/L)or Rosiglitazone(1.0,2.3,5.0,10.0μmol/L).MC proliferation was measured by ~3H-thymidine incoporation.MC cell-cycle was analyzed by flow cytometry.Cyclin D1 and cyclin A expression was determined by Western blot analysis.Reactive oxygen species (ROS)production was measured by 2',7'-dichlorofluorescein diacetate(DCFDA)fluorescence.Results:①ALDO-induced MC prolif- eration was inhibited by PPARγagonist rosiglitazone in dose-dependent manner in mouse mesangial cells;②ALDO increased cell number in S-and G_2/M phase,which was inhibited by rosiglitazone;③Rosiglitazone reduced ALDO-induced eyelin D1 and cyclin A expression in dose-dependent manner;④NAC significantly inhibited ALDO-induced MC proliferation.Rosiglitazone dose-dependently inhibited ALDO-induced ROS production.Conclusions:ROS involved in ALDO-induced MC proliferation.PPARγligand rosiglitazone blocked ALDO-induced MC proliferation via inhibition of ROS production.
Key concepts: Rosiglitazone, Cell growth, Cyclin D1, Agonist, Endocrinology, Chemistry, Internal medicine, Peroxisome proliferator-activated receptor